Health Care/Hospital
Rimegepant is Now Available in Hong Kong, the First Market in Asia, for Migraine Management
HONG KONG, Sept. 29, 2023 /PRNewswire/ -- Pfizer announced the availability of Rimegepant inHong Kong, the first market in Asia, a calcitonin gene-related peptide (CGRP) receptor antagonist for migraine management.[1],[2] There are approximately 12.5% of people living with migraine inHong Kong[3]...
#UseHeart movement rallies for change as heart disease continues to claim most lives
GENEVA, Sept. 29, 2023 /PRNewswire/ -- This World Heart Day, the World Heart
Federation (WHF) is urging all sectors and citizens to join forces and take
down cardiovascular disease (CVD) from its "number one killer" position.
Bowtie designed insurance plan for individuals aged 50+ before retirement
HONG KONG, Sept. 29, 2023 /PRNewswire/ -- As individuals in their 50s approach retirement, they not only face the loss of a stable monthly income but also the termination of group medical insurance. Considering the increased risk of illness associated with aging, having adequate coverage becomes ...
Bionomics Announces Positive Topline Results from the Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)
ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks. Statistically significant secondary endpoints showed improvements in depressive symptoms and sleep. BNC210 was well-tolerated with a safety prof...
Cutting-edge cancer imaging tool allows doctors to efficiently adapt radiotherapy treatment
First patient treated on radiotherapy system equipped with HyperSight imaging solution at Icon Cancer Centre MELBOURNE, Australia, Sept. 29, 2023 /PRNewswire/ -- An innovative technology that captures high-quality images of a tumor in six seconds is being used to guide cancer treatments for pati...
Academic Conference on "Research on Female Reproductive Health in International Perspective" Successfully Concluded
HONG KONG, Sept. 29, 2023 /PRNewswire/ -- On September 22nd, the academic conference on "Female Reproductive Health Research in International Perspective", organized by Hong Kong Research Institute of Modern Chinese Medicine for Reproductive Anti-aging(HKMCMRA), was successfully concluded in Hong...
Ascletis Announces Positive Interim Data from the Phase IIb Expansion Cohort of ASC22 (Envafolimab) for Chronic Hepatitis B Functional Cure
HANGZHOU and SHAOXING, China, Sept. 29, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces positive interim data from the Phase IIb expansion cohort (the "Expansion Cohort") of subcutaneously administered PD-L1 antibody ASC22 (Envafolimab) for functional cure of ch...
Innovent and IASO Bio Present Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023
82.4% of patients without prior CAR-T achieving Complete Response (CR) or better ROCKVILLE, Md. and SUZHOU, China, Sept. 29, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-qualit...
Jin Medical International Limited Receives NASDAQ Notification Letter Regarding Noncompliance with Continued Listing Rule 5550(a)(3)
CHANGZHOU, China, Sept. 28, 2023 /PRNewswire/ -- Jin Medical International Ltd. ("JinMed" or "the Company") (NASDAQ: ZJYL), aCayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, received a written notification letter ("t...
AMRIC, A New Premium Imaging Clinic on Manhattan's Upper East Side Featuring Cutting-Edge Scanners from United Imaging, Opens its Doors
Focusing on every detail, the clinic combines advanced multi-modality technology with highly tailored patient care to bring a new standard of preventive and diagnostic screenings to the center ofNew York City. HOUSTON, Sept. 28, 2023 /PRNewswire/ -- United Imaging, a leading global manufacturer...
SGC and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery
CHENGDU, China, Sept. 28, 2023 /PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH) today announced that it has entered into a partnership with The Structural Genomics Consortium ("SGC"), a public-private partnership that supports the discovery of new medi...
ALR Technologies Announces Patent Grant for Predictive A1C and Successful Results from Singapore General Hospital-led Study
SINGAPORE, Sept. 28, 2023 /PRNewswire/ -- ALR Technologies SG Ltd. ("ALRT" or the "Company") (OTCQB: ALRTF), a diabetes management company, announces the patent application titledMethod and System of Monitoring a Diabetes Treatment Plan("Predictive A1c") has been granted in Singapore and has rec...
Health In Tech Partners With Tall Tree Administrators to Extend Health Insurance Options for Small Businesses
The Collaboration Provides Self-Funded Clients Access to Tailored Health Plans and Ancillary Products STUART, Fla., Sept. 28, 2023 /PRNewswire/ -- Health In Tech, an industry-leading insurtech company that delivers disruptive innovation and re-imagines self-funded health plans, is excited to ann...
ProfoundBio Announces Upcoming Scientific Presentations at SITC 2023
SEATTLE, Sept. 28, 2023 /PRNewswire/ -- ProfoundBio, a clinical-stage biotechnology company focused on the development of novel antibody-drug conjugate (ADC) therapeutics for cancer, announced four upcoming poster presentations on its ADC platform and lead clinical assets, rinatabart sesutecan (...
Mabwell Announces First Patient Dosed in Phase Ib/II Trial of its Novel Nectin-4 Targeting ADC in Combination with PD-1 Inhibitor
SHANGHAI, Sept. 28, 2023 /PRNewswire/ -- Mabwell (688062.SH) , an innovative biopharmaceutical company with entire industry chain, announced the first patient was dosed in a phase Ib/II trial of its novel Nectin-4 targeting ADC (R&D code: 9MW2821) in combination with PD-1 inhibitor for the treatm...
IASO Bio Presents Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023
82.4% of patients without prior CAR-T achieving Complete Response (CR) or better SHANGHAI and NANJING, China and SAN JOSE, Calif., Sept. 28, 2023 /PRNewswire/ -- IASO Bio, a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and ant...
AIA celebrates the grand opening of "AIA Alta Wellness Haven"
Hong Kong insurance industry's first one-stop wellness realm that integrates science andEast-meets-West philosophy Amplifies AIA's High Net Worth Proposition with the establishment of "AIA Club Alta" HONG KONG, Sept. 28, 2023 /PRNewswire/ -- Following the resounding success of the launch of "A...
PATIENTS SPEAK UP ABOUT KIDNEY DISEASE
COMMUNITY HEALTH CAMPAIGN "LIVE YOUR WAY" LAUNCHES ACROSS SINGAPORE * Life with kidney disease the focus of new public health campaign * Baxter Healthcare and National Kidney Foundation partner for patients SINGAPORE, Sept. 28, 2023 /PRNewswire/ -- Baxter International, a global medtech leade...
ScolioLife® Scoliosis & Spine Correction Clinic: A Beacon of Hope for Patients
~ ScolioLife® Pioneers a Comprehensive and Holistic Approach to Scoliosis
Management ~
SINGAPORE, Sept. 28, 2023 /PRNewswire/ -- Dr Kevin Lau
Akeso Announced FDA Clearance of IND for CD47 Monoclonal Antibody (AK117) in Combination with Azacitidine in Myelodysplastic Syndromes
HONG KONG, Sept. 27, 2023 /PRNewswire/ -- Akeso, Inc. (the Company, Akeso, 9926.HK) announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for AK117, a next generation CD47 monoclonal antibody in combination with azaciti...
Week's Top Stories
Most Reposted
Co-creating a Digital and Intelligent World, H3C Digital Tour 2024 Concludes Successfully
[Picked up by 295 media titles]
2024-07-04 12:02Yidu Tech Announces Annual Results for FY 2024: Existing Business Achieves First Full-Year Profit on Adjusted EBITDA
[Picked up by 291 media titles]
2024-07-01 09:05AI and Sustainability in Advanced Manufacturing to take Centre Stage at Industrial Transformation ASIA-PACIFIC (ITAP) 2024
[Picked up by 283 media titles]
2024-07-03 15:51National Cancer Society Malaysia and Gene Solutions Forge Partnership to Expand Multi-Cancer Early Detection Awareness and Access
[Picked up by 278 media titles]
2024-07-01 12:55The Global Multimedia Deepfake Detection Challenge 2024 Officially Announced with Over $130,000 in Prizes
[Picked up by 277 media titles]
2024-07-01 16:47